Dr. Kaja Milanowska-Zabel is a precision medicine enthusiast and a bioinformatics researcher. Her personal and professional ambitions led her to exploit the importance of different data analysis approaches in human health. In 2016, Kaja joined Ardigen and started research activities, primarily in the area of oncology. In 2018, after becoming one-third of Ardigen’s management board, she took over a new position and the responsibility of the R&D projects. Currently, Kaja is a Business Development Executive and Board Member. Kaja is also broadening her knowledge in business by realising a curriculum in Executive MBA at Kozminski University in Warsaw.